Beneficio también en los pacientes BRAF mutados
Jedd Wolchok presented at 2016 ASCO Annual Meeting
CheckMate 067
- - - - BRAF mutated
BRAF mutated worse with nivolumab monotherapy?
-Not confirmed in other studies
-No differences in ORR
-BRAF mutated better benefit of the COMBO?
PFS COMBO iBRAF/iMEK: 12 months
